Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FREZYDERM is a leading Greek dermaceutical company founded in 1986 that specializes in the design, formulation, and manufacture of high-quality dermatological products. The company offers a diverse range of healthcare solutions, including specialized treatments for acne, psoriasis, and eczema, as well as comprehensive lines for baby care, hair care, and oral hygiene. FREZYDERM is particularly renowned for its innovative Sun Screen Velvet technology, which provides high UV protection through a patented Second Skin texture that is non-greasy and transparent. With a strong focus on research and development, the company operates state-of-the-art manufacturing facilities that comply with international GMP standards. FREZYDERM maintains a dominant position in the Greek pharmacy market and exports its products to over 20 countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FREZYDERM.